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Background: Gene expression is tightly regulated at both transcriptional and post-transcriptional levels. RNA-binding
proteins are involved in post-transcriptional gene regulation events. They are involved in a variety of functions
such as splicing, alternative splicing, nuclear import and export of mRNA, RNA stability and translation. There are
several well-characterized RNA-binding motifs present in a whole genome, such as RNA recognition motif (RRM),
KH domain, zinc-fingers etc. In the present study, we have investigated human genome for the presence of
RRM-containing gene products starting from RRM domains in the Pfam (Protein family database) repository.
Results: In Pfam, seven families are recorded to contain RRM-containing proteins. We studied these families for
their taxonomic representation, sequence features (identity, length, phylogeny) and structural properties (mapping
conservation on the structures). We then examined the presence of RRM-containing gene products in Homo sapiens
genome and identified 928 RRM-containing gene products. These were studied for their predicted domain
architectures, biological processes, involvement in pathways, disease relevance and disorder content. RRM domains
were observed to occur multiple times in a single polypeptide. However, there are 56 other co-existing domains
involved in different regulatory functions. Further, functional enrichment analysis revealed that RRM-containing gene
products are mainly involved in biological functions such as mRNA splicing and its regulation.
Conclusions: Our sequence analysis identified RRM-containing gene products in the human genome and provides
insights into their domain architectures and biological functions. Since mRNA splicing and gene regulation are important
in the cellular machinery, this analysis provides an early overview of genes that carry out these functions.
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The gene expression process in eukaryotes needs to be
tightly regulated at every step. Firstly, it is regulated at
the transcription level by means such as chromatin
structure, DNA sequence elements and binding of tran-
scription factors etc. [1,2]. In spite of this tight regulation,
post-transcriptional regulation plays an important role in
regulating the levels of mRNA that are expressed in all
tissues and serves as a supplement control mechanism.
The post-transcriptional regulation governs several pro-
cesses namely alternative splicing, RNA editing, transport
of RNA from nucleus to cytoplasm, RNA stability and* Correspondence: mini@ncbs.res.in
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article, unless otherwise stated.translation [1,3]. The aberrations in the regulation of gene
expression are also implicated in several human diseases
such as Huntington’s disease, leukoencephalopathy, cancer
etc. [4-6].
RNA-binding proteins (RBPs) mediate all the post-
transcriptional control events. As there are varied levels
of control and targets to be regulated, there exists a
wide repertoire of RNA-binding motifs. To achieve the
sequence-specific recognition of targets, there are sev-
eral RNA-binding domains that are well-characterized
in RBPs such as RRM (RNA recognition motif) domains,
KH domains, pumilio homology domain, zinc fingers,
double-stranded RNA binding motifs (dsRBMs) [7,8].
RRM is the most abundant RNA-binding domain in
higher vertebrates and is also known as RNA binding
domain (RBD) or ribonucleoprotein domain (RNP) [9].ioMed Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
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conserved motifs, RNP1 and RNP2, which are rich in aro-
matic amino acids. RRM structure possesses β1α1β2β3α2β4
topology, containing a four-stranded β –sheet which is
packed against two α-helices [7,9]. RNP1 is eight amino
acids long and is present on β3 and RNP2 (six amino
acids) is present on β1 [9]. Recently, RRM domains are
also reported to be associated with the RNA-binding prion
candidate proteins [10]. Birney et al., performed an ana-
lysis on 125 sequences (possessing 252 RRM) of splicing
factors and reported three solvent-exposed aromatic con-
served residues in RNP-1 and RNP-2, which are impli-
cated in RNA-binding [11].
Detailed study of RRM domains and their functions in
the available sequenced genomes will help to improve
our understanding and functions of RBPs. RBPs can be
identified by the identification of RNA-binding domains
in a given genome of interest. There have been several
attempts to perform genome-wide analysis for specific
RBPs in various organisms such as in Drosophila mela-
nogaster, Mus musculus, Arabidopsis thaliana, sponge
Amphimedon queenslandica, C.elegans, and yeast ge-
nomes [12-16]. This has led to identification of several
RBPs in these genomes and 5-8% of genes are reported to
encode RBP in yeast and ~2% in C. elegans, D. melanoga-
ster and mouse. These studies provide insight into the dis-
tribution of RBPs and their classes in the genome being
examined and their underlying functions.
In the present study, we have performed sequence
searches in the human genome. We first studied the
RRM-containing protein families in the Pfam database
[17-20] for their taxonomic distribution, sequence features
(sequence identity, phylogeny) and mapped conserved res-
idues on their structures. We employed the profiles built
using the members of these families to perform searches
in the Homo sapiens genome. The gene products that
retain sequence signatures of RRM-domains were next
studied for their domain architectures, biological processes,
pathways and disease relevance.Table 1 RRM families in Pfam database
Pfam ID Pfam name Descripti
PF00076 RRM_1 Clan RRM, has splicing factor
nucleic acid binding. W
PF04059 RRM_2 Clan RRM, Meiosis
PF08777 RRM_3 Clan RRM, La protein (RNA c
Beta sheet (atyp
PF10598 RRM_4 PrP8 protein (Large RNA protein
PF13893 RRM_5 Clan RRM, h
PF14259 RRM_6 Clan RR
PF10378 RRM Found only in fungi, putative
There are seven families defined in Pfam based on their gathering threshold values
sequences in Pfam.
*The numbers in brackets represent the full set members when the seed sequenceResults and discussion
RRM families in Pfam
There are seven families in the protein sequence family
database (Pfam), which possess RRM domains (Table 1).
We studied these families for their sequence features,
taxonomic distributions and structural features (Figure 1).
RRM domains are known to be ~80-100 amino aids in
their length [9] and Figure 2 shows the length distribution
of the members for the seven RRM families in Pfam data-
base. The proteins possessing RRM domains are present
mainly in Eukaryota (Metazoa, Viridiplantae, Fungi king-
doms). But there is very little representation of RRM_1
domain in Bacteria (Additional file 1).
(i) Sequence features
We examined the sequence dispersion of members within
and across the seven families for the distribution of se-
quence identities among and across family members and
domain lengths.
RRM domains from the members of the same families
were observed to be very diverse at the sequence level
(Figure 3). The average sequence identity (Figure 3A) of
the seven RRM families was <40% for four families
(RRM_1, RRM_3, RRM_5 and RRM_6). The distribution
of sequence identities between members of the same fam-
ily is plotted in form of a Box-Whisker plot (Figure 3B).
Across the different RRM families, as expected, the
average percentage identity was <20%. However, across
families of RRM_1, RRM_5 and RRM_6, some members
share high sequence identity, as shown in Additional
file 2.
The Pfam seed sequences from all the seven RRM
families were employed (full set if seed set contains <50
sequences, Table 1) to generate phylogeny using neighbor-
joining method using ClustalW [21,22], Additional file 3A)
and maximum-likelihood (PhyML [23], Additional file 3B)
method. Sequences from families RRM_1, RRM_5 and
RRM_6 were observed to co-cluster, consistent with the
observation of distribution of sequence identities (pleaseon Number of Pfam seed sequences
and GO annotation as
ell-characterised
79




complex of spliceosome) 25* (233)
nRNP 107
M 79
RNA binding domain 7* (74)
. The families are listed with their description and the number of seed
s are less than 50 in number.
Figure 1 Overall schema of the methodology and analysis. The figure highlights the analysis performed on RRM-containing Pfam families
and the methodology adopted to perform genome-wide survey in Homo sapiens genome.
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using MUSCLE 3.8 [24] and built a new neighbor-joining
tree using MEGA 6 [25] (Additional file 3C) using 500
bootstraps. The co-clustering of the members belonging
to the three Pfam-defined families (RRM_1, RRM_5 and
RRM_6) was still persistent. Therefore, we defined new
distinct clusters derived from the phylogeny (Additional
file 3C, inner circle). The sequences of these clusters were
re-aligned using MUSCLE 3.8 [24] and their PSSM and
HMM profiles were created (please see Methods for
details) to perform the searches in the human genome.
(ii) Structural features
Four of the seven families have structural representation
in the Protein Data Bank (PDB) [26]. The alignments forFigure 2 Length distribution within RRM family members in Pfam dat
members. (a) Average amino acid length of a RRM family and (b) The distr
families in Pfam.the seven families were analyzed for the conservation of
residues using ConSurf [27]. The conserved residues
were mapped on the structures from each of the Pfam
RRM family (Figure 4). We observed that the conserved
residues map to the same structural region. This obser-
vation, together with the percentage similarity plots
(across families, Additional file 2) explains the cause of
co-clustering observed between the members of the
different RRM families. Therefore, as explained above,
we made distinct clusters based on sequence identities
to perform searches in the human genome.
Searches in the human genome and validation
Both PSSM and HMM profiles of the new clusters
(please see Methods for details) were employed toabase. We studied the protein length distribution of RRM families’
ibution of amino acid lengths of the members of the seven RRM
Figure 3 Sequence identity within RRM families’ members. We studied the sequence diversity between the members within a RRM family.
(a) It shows the average sequence identities of different families and (b) The distribution of percentage sequence identity of the seven RRM
families in Pfam.
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containing gene products using RPS-BLAST [28,29]
and HMMscan [30] respectively. 928 RRM-containing
gene products were thus identified in the human genome
purely by sequence searches (Additional file 4). Of these,
50% (452 gene products) are unreviewed proteins andFigure 4 Conservation mapping on RRM structures. The multiple seque
sequence conservation and the conserved residues were mapped to the R
family-RRM, there is no structural representation and we therefore, used str
RRM_2, (c) RRM_3 (1OWX, chainA), (d) RRM_4, (e) RRM_5 (1A9N, chain d),belong to UniProt/TrEMBL. Subsequent to the clustering
using BLASTCLUST [31,32] (at 98% sequence identity),
403 human gene products were retained. 84% of these
(340 gene products) are annotated in Gene Ontology
(GO) database [33] for their molecular functions. Out of
these, 337 gene products were annotated as RNA-bindingnce alignments for each of these families were employed to study
RM structures (in green). However for the families RRM_2, RRM_4 and
ucture of RRM_1 family for mapping. (a) RRM_1 (1L3K, chainA), (b)
(f) RRM_6 (1WG5, chain a) and (g) RRM.
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terms) in GO.
Length distribution
The full-length distribution of the RRM-containing gene
products identified by sequence searches was next ana-
lyzed. RRM is a small domain of ~80-100 amino acids;
however, we observed that most of the RRM-containing
human hits are >150 amino acids in length (Figure 5).
This implies that there are other co-existing domains or
multiple RRM domains or unstructured regions ac-
companying RRM domains in the full-length human
gene products that contain RRM domains.
Domain architectures (co-existing domains)
The full-length RRM-containing human gene products
were also analyzed for their complete domain architectures
using HMMScan [30] against HMM profiles of Pfam
families. Such a search enabled the association of RRM
domains identified in the human genome into any one
of the known seven families in Pfam database as well.
RRM_1 (PF00076) is the most well-characterized and
well-populated RRM family in the Pfam database. 79%
of the identified human RRM-containing gene products
possess RRM_1 domain. In Pfam database, RRM_1 is
present in larger fraction of protein sequences of the
class Mammalia as compared to other six RRM families
(Additional file 1). Out of the seven RRM families inFigure 5 Length distribution of the RRM-containing human gene pro
products that were identified as RRM-containing.Pfam, we observed that two families (RRM_2 and RRM)
have no representation in the human genome. There are
no sequences from the class mammalia for these two
families in the Pfam database also. RRM is a fungal-
specific family and RRM_2 is found only in Viridiplantae
and fungi (Additional file 1).
We further analyzed the co-existing domains and ob-
served that in 13 gene products (where isoforms are
reported), the number of RRM occurrence and co-existing
domains are different (Table 2). This implies that may be
during the alternative splicing event full domains are also
spliced out. Figure 6 highlights the ten most frequent do-
main architectures observed in RRM-containing human
gene products in a schematic form drawn. 40% of the gene
products contain no other recognizable co-existing do-
main, whereas rest of the sequences possesses either
multiple RRM domains or other co-existing domains.
The gene products containing a single domain connect
to RRM_1/RRM_5/RRM_families and map to their
biological processes using GO annotations. 39 of these
gene products are annotated with their biological
process (Additional file 5).
Genes containing multiple RRM domains were present
in 28% of the RRM-containing human hits (Figure 7)
and this event is a frequent occurrence almost as a rule
[9,34]. There are 56 non-RRM co-existing domains
(Additional file 6) which were noted for their functions
and are observed to be involved in a variety of cellularducts. We studied the protein length distribution of the human gene
Figure 6 Domain architectures of the RRM-containing human
gene products. We studied the human gene products for the
presence of the co-existing domains. The schematic diagram displays
the most frequent domain architectures drawn using the software
DOG 1.0.
Table 2 Domain architectures in isoforms
Domain architecture Human protein Domain architecture Human protein
RRM_1,RRM_1,RRM_1 O60506 PWI, RRM_5,RRM_5 Q5T8P6
RRM_1,RRM_1 O60506-2 PWI, RRM_5,RRM_5 Q5T8P6-2
RRM_1,RRM_1,RRM_1 O60506-3 PWI, RRM_5,RRM_5 Q5T8P6-3
RRM_1,RRM_1 O60506-4 RRM_5,RRM_5 Q5T8P6-4
RRM_1,RRM_1,RRM_1 O60506-5 RRM_5,RRM_5 Q5T8P6-5
La, RRM_1,RRM_3 Q4G0J3 RRM_1,RRM_1 Q86SG3
RRM_3 Q4G0J3-2 RRM_1 Q86SG3-2
RRM_5 O95628 RRM_1,RRM_1,RRM_1,RRM_1 Q8IUH3
RRM_5 O95628-2 RRM_1,RRM_1,RRM_1 Q8IUH3-2
RRM_5 O95628-3 RRM_1,RRM_1,RRM_1,RRM_1 Q8IUH3-3
zf-C3HC4_3,RRM_5 O95628-4 RRM_1,RRM_1,RRM_1 Q8N6W0
RRM_5 O95628-5 RRM_1,RRM_1 Q8N6W0-2
RRM_5 O95628-6 zf-CCCH,zf-CCCH Q8WU68
zf-C3HC4_3,RRM_5 O95628-7 zf-CCCH Q8WU68-2
zf-C3HC4_3,RRM_5 O95628-8 zf-CCCH,zf-CCCH Q8WU68-3
RRM_6,RRM_6 P31942 RRM_5,RRM_5,RRM_5 Q8WVV9
RRM_6,RRM_6 P31942-2 RRM_5,RRM_5 Q8WVV9-2
RRM_6,RRM_6 P31942-3 RRM_5,RRM_5 Q8WVV9-3
RRM_6 P31942-4 RRM_5,RRM_5,RRM_5 Q8WVV9-4
RRM_6 P31942-5 RRM_1,RRM_1,RRM_1 Q96J87
RRM_6 P31942-6 RRM_1,RRM_1 Q96J87-2
RRM_1,RRM_1,RRM_1 Q9P2K5 RRM_1,RRM_1,RRM_1 Q96J87-3
RRM_1,RRM_1,RRM_1 Q9P2K5-2 RRM_1,RRM_1 Q96J87-4
RRM_1 Q9P2K5-3
928 RRM-containing gene products were studied for their co-existing domains. We observed that in 13 gene products where isoforms are reported the domain
architectures are different. This implies may be during the alternative splicing event full domains are also spliced out.
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transcriptional regulation, splicing and alternative splicing
(Additional file 6). We also noted these co-existing do-
mains for their frequency of occurrence in the human
gene products (Additional file 7). As observed by the func-
tions of co-existing domains, RRM containing gene prod-
ucts possess other RNA as well as protein binding
domains, which might govern their specificity and affinity
towards their RNA targets and assist them in performing
their diverse biological functions.Enrichment analysis
We studied the RRM domain-containing human gene
products for their involvement in biological processes
using DAVID 6.7 [35,36]. They were observed to be in-
volved in various processes involved in RNA metabolism.
We further identified the biological processes, which were
enriched in the RRM-containing gene products based on
normalization using the biological processes performed by
all the human gene products as background. Out of the
Figure 7 Modular nature of RRM. Within a single polypeptide sequence, RRM domain was observed to occur multiple times in 108 of the
human gene products. This figure highlights the distribution of different RRM domains and their multiple occurrences. RRM_1 is present most
frequently (88 of the gene products) and is repeated twice within a single protein sequence.
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biological processes in DAVID 6.7. Upon functional
clustering, these belong to 22 clusters. Upon filtering the
results based on Bonferroni correction method (p < 0.05),
42 gene products were observed to belong to six biological
processes performing mRNA processing and RNA spli-
cing (Figure 8, Additional file 8).
Using DAVID 6.7, we also studied the KEGG pathway
[37] enrichment in this set of human RRM-containing
gene products. Upon performing functional clustering
and using the same filtering parameters as explained
above, 33 gene products were observed to be part of the
spliceosome machinery (Additional file 9).
Disease involvement and disorder content
The set of RRM-containing human gene products were
further analyzed for their role in diseases and disorder
content. We obtained a comprehensive list of RNA-bindingFigure 8 Enrichment analysis for biological processes. The RRM-contai
based enrichment analysis using DAVID 6.7. The processes, which were obs
its regulation.proteins which are linked to Mendelian diseases in human
(as recorded in OMIM database) from a recent review [38].
There are 157 RNA binding Ensembl gene models that
are implicated in Mendelian diseases [38]. We mapped
these to the RRM-containing gene products identified
in our analysis. 14 of these RNA-binding proteins linked
with Mendelian diseases contain RRM domain (Additional
file 10).
As ageing is reported as a risk factor for neurode-
generation and the role of RNA-binding proteins is
implicated in neurodegeneration [39-41], we ana-
lyzed the disorder content of the RRM-containing
gene products. Their disorder content of was ana-
lyzed using DISOPRED [42]. 16% of the gene prod-
ucts (Additional file 11) were high (>0.7) in their
disorder content (% of disordered residues) and such
gene products could be involved in processes such as
ageing [39-41].ning human gene products were studied for their functional clustering
erved to be enriched were related to mRNA processing, splicing and
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RNA-binding proteins govern gene regulatory events
at the post-transcriptional level. There are several well-
characterized RNA-binding motifs present in the protein
partner. Of these, RRM are the most abundant in higher
vertebrates. In the present work, the genome-wide survey
for the presence of RRM-containing gene products was
performed in the human proteome, employing compu-
tational approaches starting from the known RRM-
containing sequences present in the Pfam database.
The seven RRM families in Pfam are derived based on
the HMM-HMM comparisons using a gathering threshold
(GA threshold). GA thresholds are Pfam-bit scores and es-
timates of significance of hits. We studied these families
for their features. We observed:
1. Taxonomic representation: The majority of the
sequences belonging to these families are present in
Eukaryota, with few bacterial RRM-containing
proteins in the family RRM_1. RRM_2 and RRM
Pfam families are not present in the class Mammalia
and are present only in plants and fungi.
2. Sequence features: The members within the families
are more similar as compared to other family
members, as expected. However, some of the
members of RRM_1, RRM_5 and RRM_6 families
share high (>50%) sequence identity.
3. The conservation of amino acid residues was studied
using ConSurf and mapped on the protein structures
from each of the RRM families. The conserved
residues were localized on similar structural regions.
We identified 928 gene products (403 gene products
at 98% sequence identity), which contain RRM domain in
the human genome upon performing the genome-wide
scan using profile-based sequence search methods. As
documented in existing literature, RRM is an abundant
domain in eukaryotes [7,15,43,44] and we also observed
that 50% of the reported RNA-binding proteins (860
RNA-binding proteins, experimentally characterized by
isolating mRNA interactome) in the human genome
from a recent study [45] possess RRM domain. Their
full-length sequences were analyzed for domain archi-
tectures in order to understand their functional roles.
As RNA-binding proteins are known to mediate variety
of different interactions and regulatory functions, ana-
lyzing the domain architectures of these full-length gene
products will provide an insight into understanding of
their evolution and biological functions. RRM_1 domain
is present in majority of these human gene products
(79%). 60% of the gene products were observed to possess
multiple domains (either multiple RRM or non-RRM co-
existing domains). RRM-containing proteins are known to
possess modular nature (multiple repeats of RRM) [9,34].The length of the linker between the different RRM do-
mains is known to govern specificity of RNA-binding, since
a single RRM domain can bind from only four to eight nu-
cleotides [9]. Therefore, modular nature of these proteins
confer specificity to bind the target RNA as the number of
nucleotides identified by single RRM domain is too small to
define a unique target. The non-RRM co-existing domains
were observed to be involved in functions like developmen-
tal signaling, apoptosis, transcriptional regulation, splicing
and alternative splicing suggesting fundamental cellular
roles of such genes.
The set of RRM-containing human gene products were
mapped for their biological processes and pathways. The
biological processes which were enriched in these gene
products were related to mRNA splicing and its regula-
tion. 33 of gene products were involved in the spiceosomal
pathway. There are more than 100 gene products that are
known to be part of the spiceosome. It is recently reported
that more than half of the proteins in the spliceosome are
intrinsically disordered (when proteins are considered in
isolation) [46,47]. These intrinsically disordered proteins
are also implicated in age related neurodegenerative dis-
eases [39-41]. One of the RRM-containing human gene
product that encodes for FUS protein (fused in sarcoma,
546 amino acids long), is predicted to possess only 50
amino acids, which form a folded structure [39]. We cal-
culated the fraction of disorder residues (low sequence
complexity, rich in hydrophilic and aromatic residues) in
the human RRM-containing gene products and observed
that 16% of these are rich in disordered regions. It will
be interesting to follow if these intrinsically disordered
regions become structured upon binding to their RNA
targets.
Also, recently RRM domain proteins have been impli-
cated in several Mendelian diseases [38] and are observed
to possess prion-forming ability [10,48]. Therefore, we
mapped these gene products to OMIM database and 14 of
the human gene products were linked to Mendelian dis-
eases. This study will help in characterization of RRM-
containing gene products in the human genome and to
provide early bioinformatics view of their functions.
Methods
Human proteome
The entire proteome of Homo sapiens, comprising of both
reviewed and unreviewed entries, was downloaded from
UniProt FTP website (http://www.uniprot.org/downloads).
This set of human sequences was used to perform the
genome-wide survey.
RRM families
To perform searches in the human genome, we collated
the known RRM sequences from the protein family data-
base [17-20] (PFam). Pfam clusters sequences on the
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seven different families. We studied these families for
their sequence-based features like sequence identities
and length distributions. The family alignments were
employed to identify conserved sequence motifs using
ConSurf [27] and these motifs were mapped on the
structures of the RRM families. The sequences belonging
to these families were also studied for their taxonomic
distributions in various kingdoms and classes.
Search protocol and its validation
The RRM-containing sequences belonging to the seven
PFam families were used to perform searches in the hu-
man genome. Based on the phylogenetic tree analysis,
these families were clustered into 10 new distinct clusters.
The profiles of the new clusters were employed to perform
searches in the human genome.
The multiple sequence alignment for all the members
for each of the clusters was performed using MUSCLE
3.8 [24]. All the phylogenetic trees were visualized using
FigTree 1.4.0 [49]. Subsequently, the human genome was
searched using sensitive profile-based sequence search
methods, RPS-BLAST [28,29] and HMMScan [30].
1. We built PSI-BLAST profiles (position-specific
substitution matrix) for each cluster, using the
alignment of cluster members as an input against
NR database at an Evalue = 10−10. A database of
profiles of all the clusters was generated. The human
gene products were searched against this database of
profiles using RPS-BLAST at Evalue = 10−3.
2. For each of the cluster, we also generated HMM
profiles using the alignment as an input. The entire
human proteome was also searched against the
HMM profiles of all clusters to identify putative
RRM-containing gene products using HMMScan
and an Evalue = 10−2.
The RRM-containing gene products identified in the
human genome were further subjected to validation using
GO annotations available for the human proteome [33].
We filtered them based on GO terms, RNA binding and
nucleotide binding including their child terms.
Analysis of RBP identified in human genome
These full-length gene products that contain sequence
signature for at least one RRM domain were analyzed
for their length distributions.
1. Domain architectures
The identified gene products were further filtered to
remove isoforms, fragments and highly similar
sequences, by clustering them using BLASTCLUST
[31,32] at 98% sequence similarity over an areacovering 50% of the length. We then studied the
domain architectures using HMMScan against a
database of entire Pfam HMM profiles at 10−5. The
domain architectures were observed for
RRM-repeats and non-RRM co-existing domains
were noted for their functions. The schematic for
domain architectures was drawn using the software
DOG 1.0 [50].
2. Biological processes and pathways
The identified RRM-containing human gene products
were also mapped to their biological processes and
the enrichment study for these processes was
performed using DAVID 6.7 [35,36]. Upon functional
clustering, the results were filtered based on Bonferroni
correction (p <0.05). We also studied these gene
products for their pathway mapping in the KEGG
database [37] using DAVID 6.7 [35,36].
3. Disease implications and disorder content
The gene products were further mapped to OMIM
[51] database using DAVID 6.7 [35,36]. The disorder
analysis was performed using DISOPRED [42]. All
the residues were analyzed for their disorder and the
disorder content (fraction of disordered residues) for
these gene products was calculated.Additional files
Additional file 1: Is a table listing the taxonomic representation of
RRM families.
Additional file 2: Is a figure, which highlights the percent sequence
identity across different RRM families (In the Additional file 2, r1
stands for RRM_1, r2 for RRM_2, r3 for RRM_3, r4 for RRM_4, r5 for
RRM_5, r6 for RRM_6 and r for RRM family. R1_r2 implies percent
identity distribution between the members of RRM_1 and RRM_2 families
and likewise for other combinations).
Additional file 3: Is a figure that shows the co-clustering between
members belonging to different RRM families (A. Neighbor joining
tree-using ClustalW, B. Maximum-likelihood tress using PhyML and C.
Neighbor joining tree using MEGA 6 and employing alignment derived
from MUSCLE 3.8). The color code followed is: RRM_1: Blue, RRM_2:
Brown, RRM_3: Red, RRM_4: Pink, RRM_5: Yellow, RRM_6: Green and RRM:
Cyan.
Additional file 4: Is a table listing the RRM-containing gene products
identified in the human genome.
Additional file 5: Is a table listing the single domain RRM-containing
human gene products and their molecular functions.
Additional file 6: Is a table listing the non-RRM co-existing domains
with their functions present in the set of human RRM-containing
gene products.
Additional file 7: Is a figure that shows the frequency of co-existing
domains in the RRM-containing human gene products.
Additional file 8: Is a table listing the enriched GO functions in
RRM-containing human gene products.
Additional file 9: Is a figure that highlights the gene products
involved in spilceosome pathway (In red the spliceosome
components that contain the gene products we identified upon
genome-wide survey are marked). The figure displays all the
components that are known to be part of spliceosome pathway (as in
Malhotra and Sowdhamini BMC Genomics 2014, 15:1159 Page 10 of 11
http://www.biomedcentral.com/1471-2164/15/1159KEGG). The gene products, which were identified using our search
strategy, are marked with red stars.
Additional file 10: Is a table listing the 14 human RRM-containing
gene products with implications in Mendelian diseases.
Additional file 11: Is a table listing the predicted disorder content
in the RRM-containing gene products identified in the human
genome.
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